SMARCC2 and attention deficit-hyperactivity disorder: The clinical presentation of our patients supports a redefinition of SMARCC2‐related diseases, which include mild to moderate DD, mild ID, facial dysmorphism, mild speech delay, hypotonia, feeding difficulties, brain abnormalities, attention deficit hyperactivity disorder (ADHD), and autistic behaviors.